Clinical Trials Browser

Phase 1/2 × Uveal Melanoma × Interleukin-2 × Clear all

NCT06961357 2025-12-03

Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma

Phase 1/2 Recruiting

Uveal Melanoma, Melanoma